已收盘 10-08 16:00:00 美东时间
0.000
0.00%
Viridian Therapeutics (VRDN) priced upsized concurrent public offerings totaling $350M in gross proceeds, including $225M of 1.75% convertible senior notes due 2032 and $125M of common stock. The conv...
05-07 13:36
Viridian prices USD 225 million 1.75% convertible senior notes due 2032 Viridian priced USD 225 million of 1.75% convertible senior notes due 2032 in an upsized public offering. Net proceeds from debt offering, combined with concurrent equity sale, expected at about USD 334.7 million. Interest payab
05-07 11:17
Viridian prices upsized USD 225 million 1.75% convertible senior notes due 2032 Viridian Therapeutics priced USD 225 million of 1.75% convertible senior notes due 2032 in an upsized underwritten public offering. Deal expected to close May 11, 2026. Initial conversion rate set at 40.5680 shares per U
05-07 11:13
Earnings Call Insights: Hercules Capital (HTGC) Q1 2026 Management View "In the first quarter of 2026, Hercules delivered another strong quarter of record originations, record total investment income ...
05-06 11:23
Hercules Capital, Inc. ( ($HTGC) ) just unveiled an announcement. On April 30, ...
05-06 06:39
Hercules Capital press release (HTGC): Q1 NII of $0.48 beats by $0.02. Total investment income of $141.5M (+18.4% Y/Y) in-line. More on Hercules Capital Hercules Capital: Big Commitments, Big Premium ...
05-06 05:23
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
An announcement from Hercules Capital, Inc. ( ($HTGC) ) is now available. On Ap...
05-05 05:47
Effective May 18, 2026, Seth Meyer, who has served as Chief Financial Officer since 2019, will be promoted to President. Succeeding him as Chief Financial Officer effective May 18, 2026, is Andrew Olson, a seasoned
05-04 18:05